Mylan Laboratories Limited (Mylan Labs), a subsidiary of U.S.-based Mylan Inc. (Nasdaq: MYL), is one of the world’s largest manufacturers and suppliers of active pharmaceutical ingredients (APIs). Based in Hyderabad, India, Mylan Labs offers more than 150 APIs and intermediates to customers in more than 80 countries across a wide range of therapeutic categories.
Mylan Labs maintains an impressive portfolio of finished dosage forms (FDF) of generic antiretrovirals (ARVs), used to treat adults and children living with HIV/AIDS in more than 100 countries. Mylan’s product offerings also include complex solid dosage forms for markets across the world.
Mylan Labs operates multiple state-of-the-art API and FDF facilities located in India and China. They operate with the highest standards of quality and regulatory compliance. The facilities are certified by global regulatory bodies such as the U.S. Food and Drug Administration, the World Health Organization - Geneva, the European Directorate for the Quality of Medicines, Australia’s Therapeutic Goods Administration, Medicines and Healthcare products Regulatory Agency, Medicines Control Council, etc. Our research and development (R&D) facilities around Hyderabad, with a workforce of more than 600 scientists, relentlessly innovates technologies to develop API and FDFs.
Overall, Mylan Labs has a workforce of more than 9,000 in India and China to support its businesses. The company provides opportunities to learn, grow and be a part of an energetic, value-based company that strives to make a real difference in the world.
Our parent company, U.S.-based Mylan Inc., and its affiliates, rank among the world’s leading generics and specialty pharmaceutical companies and provide products to customers in more than 150 countries and territories. Mylan maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline. With its global workforce of more than 18,000, Mylan works around the clock and around the globe to help provide the world’s 7 billion people access to high quality medicine. Our global network of employees is obsessed with quality and dedicated to Innovation, Integrity, Reliability, Service and Teamwork.